FindTrial
Sign In

Nasal decongestant as a Gingival Retraction Agent

Evaluation of A Adrenomimetic Decongest agents for gingival retraction: An in-vivo study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011613
Enrollment
15
Registered
2018-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Naphazoline: 0.01% Control Intervention1: Tetrahydrozoline and Aluminium Chloride: 0.05% and 10 %

Sponsors

Ajita Rathi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy Patients 2. Healthy Periodontium

Exclusion criteria

Exclusion criteria: 1. Pregnant and Lactating Women 2. Gingival Recession 3. Orthodontic treatment 4. Allergic to Naphazoline, tetrahydrozoline and Aluminium chloride

Design outcomes

Primary

MeasureTime frame
Naphazoline may prove to be an effective gingival retraction agentTimepoint: 10 minutes after placement - impression will be made—

Secondary

MeasureTime frame
Naphazoline may prove to be as effective and less harmful than the commonly used agentsTimepoint: 15 minutes—

Countries

India

Contacts

Public ContactAjita Rathi

Army College of Dental Sciences

aj.rathi110@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026